Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C I Edvard Smith

Showing results (171-180 of 186) with videos related to

Pageof 19
Sort By:
RSC Chemical Biology|April 2, 2025
Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate the phenotype in <i>BTK</i>/<i>Tec</i> double deficient X-linked agammaglobulinemia modelBurcu Bestas, H Yesid Estupiñán, Qing Wang, et al.
Science Translational Medicine|July 12, 2023
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised statesThomas R Müller, Takuya Sekine, Darya Trubach, et al.
Nucleic Acids Research|January 20, 2011
Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivoSamir E L Andaloussi, Taavi Lehto, Imre Mäger, et al.
Journal of Clinical Immunology|November 15, 2025
Bronchiectasis, Low IgG Levels and Lack of Vaccination are Risk Factors for Covid-19 Hospitalization in X-linked Agammaglobulinemia - A Retrospective Multicenter StudyCaroline Stenlander, Hannes Lindahl, Emelie Wahren-Borgström, et al.
Ebiomedicine|December 3, 2021
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trialPeter Bergman, Ola Blennow, Lotta Hansson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 26, 2025
Inborn errors of immunity: manifestation, treatment, and outcome - an ESID registry 1994-2024 report on 30,628 patientsGerhard Kindle, Mickaël Alligon, Michael H Albert, et al.
Journal of Human Immunity|December 5, 2025
Inborn errors of immunity: Manifestation, treatment, and outcome-an ESID registry 1994-2024 report on 30,628 patientsGerhard Kindle, Mickaël Alligon, Michael H Albert, et al.
Med (New York, N.Y.)|January 25, 2022
Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individualsKatie Healy, Elisa Pin, Puran Chen, et al.
Nature Biomedical Engineering|October 7, 2021
Amelioration of systemic inflammation via the display of two different decoy protein receptors on extracellular vesiclesDhanu Gupta, Oscar P B Wiklander, André Görgens, et al.
Molecular Immunology|May 8, 2009
Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort studyBeáta Tóth, Alla Volokha, Alexander Mihas, et al.
Pageof 19

Showing results (171-180 of 186) with videos related to

Sort By:
Pageof 19
RSC Chemical Biology|April 2, 2025
Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate the phenotype in <i>BTK</i>/<i>Tec</i> double deficient X-linked agammaglobulinemia modelBurcu Bestas, H Yesid Estupiñán, Qing Wang, et al.
Science Translational Medicine|July 12, 2023
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised statesThomas R Müller, Takuya Sekine, Darya Trubach, et al.
Nucleic Acids Research|January 20, 2011
Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivoSamir E L Andaloussi, Taavi Lehto, Imre Mäger, et al.
Journal of Clinical Immunology|November 15, 2025
Bronchiectasis, Low IgG Levels and Lack of Vaccination are Risk Factors for Covid-19 Hospitalization in X-linked Agammaglobulinemia - A Retrospective Multicenter StudyCaroline Stenlander, Hannes Lindahl, Emelie Wahren-Borgström, et al.
Ebiomedicine|December 3, 2021
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trialPeter Bergman, Ola Blennow, Lotta Hansson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 26, 2025
Inborn errors of immunity: manifestation, treatment, and outcome - an ESID registry 1994-2024 report on 30,628 patientsGerhard Kindle, Mickaël Alligon, Michael H Albert, et al.
Journal of Human Immunity|December 5, 2025
Inborn errors of immunity: Manifestation, treatment, and outcome-an ESID registry 1994-2024 report on 30,628 patientsGerhard Kindle, Mickaël Alligon, Michael H Albert, et al.
Med (New York, N.Y.)|January 25, 2022
Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individualsKatie Healy, Elisa Pin, Puran Chen, et al.
Nature Biomedical Engineering|October 7, 2021
Amelioration of systemic inflammation via the display of two different decoy protein receptors on extracellular vesiclesDhanu Gupta, Oscar P B Wiklander, André Görgens, et al.
Molecular Immunology|May 8, 2009
Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort studyBeáta Tóth, Alla Volokha, Alexander Mihas, et al.
Pageof 19